- US-listed companies
- COSCIENS Biopharma Inc.
- Balance sheet
COSCIENS Biopharma Inc. (CSCID) Balance sheet
Market cap
$36.82M
P/E ratio
| 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Cash and cash equivalents | 8 | 15 | 8 | 24 | 65 | 51 | 34 | 16 | 7 |
| Total cash & short-term investments | 8 | 15 | 8 | 24 | 65 | 51 | 34 | 16 | 7 |
| Accounts receivable, net | 0 | 0 | 1 | 2 | 1 | 1 | 0 | 2 | 1 |
| Inventories | - | - | - | - | - | - | 0 | 3 | 1 |
| Total current assets | 9 | 16 | 11 | 28 | 71 | 55 | 36 | 24 | 12 |
| Property, plant and equipment, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11 | 10 |
| Total non-current assets | - | - | - | - | - | 1 | 1 | 11 | 10 |
| Total assets | 22 | 25 | 20 | 37 | 80 | 56 | 37 | 35 | 21 |
| Total current liabilities | 6 | 6 | 6 | 5 | 8 | 7 | 5 | 7 | 4 |
| Total non-current liabilities | - | - | - | - | - | 13 | 14 | 15 | 14 |
| Total liabilities | 25 | 23 | 22 | 24 | 27 | 20 | 19 | 22 | 18 |
| Retained earnings | -314 | -310 | -317 | -323 | -335 | -352 | -370 | -12 | -21 |